ArticlePregnancy (Hoboken, N.J.)2026
Co-occurring opioid and stimulant use disorder and the relationship to severe maternal morbidity.
Article in Pregnancy (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: To evaluate the impact of the use of opioids, stimulants, or both on the rates of various severe maternal morbidity (SMM) events during inpatient delivery-related hospitalizations among patients with substance use disorder (SUD). Methods: We performed a cross-sectional analysis of inpatient pregnancy hospitalizations from the Healthcare Cost and Utilization Project (HCUP) National Inpatient Sample (NIS) from 2016 to 2022. Hospital and core files were linked and cross-referenced for demographic information. International classification of diseases (ICD) 10 codes were used to identify patients with SUD who had an SMM event during a delivery hospitalization. SMM was defined as a composite of individual maternal morbidity diagnoses, as characterized by the centers for disease control (CDC). Survey-weighted multivariable logistic regression models estimated the adjusted odds of SMM among delivery hospitalizations of patients with opioid use disorder (OUD), stimulant use disorder (StUD), or co-occurring OUD and StUD, using delivery hospitalizations of patients without any SUD as the reference group. Models adjusted for maternal age, race/ethnicity, primary insurance payer, household income quartile, hospital region, hospital location and teaching status, hospital bed size, cohort year, and Elixhauser comorbidity score. Prevalence of composite SMM and individual SMM events was compared across exposure groups using Rao-Scott chi-square tests. Results: Of the 4,804,219 delivery-related inpatient pregnancy hospitalizations over the study period, 45,671 admissions were identified as having SUD with either opioids (28,464), stimulants (13,920), or both (3287). There was an increasing trend of StUD from 2016 to 2021 ( Conclusion: Pregnant people with co-occurring OUD and StUD are at a significantly increased risk of SMM overall, as well as risk of certain individual SMM events as compared to those with OUD or StUD alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.